John Bigalke T.'s most recent trade in Premier Inc - Ordinary Shares - Class A was a trade of 1,137 Class A Common Stock done at an average price of $17.5 . Disclosure was reported to the exchange on March 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Premier Inc - Ordinary Sha... | John T. Bigalke | Director | Sale of securities on an exchange or to another person at price $ 17.54 per share. | 05 Mar 2025 | 1,137 | 29,810 (0%) | 0% | 17.5 | 19,943 | Class A Common Stock |
Premier Inc - Ordinary Sha... | John T. Bigalke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 7,101 | 30,947 (0%) | 0% | 0 | Class A Common Stock | |
Premier Inc - Ordinary Sha... | John T. Bigalke | Director | Sale of securities on an exchange or to another person at price $ 22.19 per share. | 05 Dec 2024 | 1,136 | 23,846 (0%) | 0% | 22.2 | 25,208 | Class A Common Stock |
Premier Inc - Ordinary Sha... | John Bigalke T. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 7,333 | 24,982 (0%) | 0% | 0 | Class A Common Stock | |
Premier Inc - Ordinary Sha... | John T. Bigalke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 4,636 | 17,649 (0%) | 0% | 0 | Class A Common Stock | |
Premier Inc - Ordinary Sha... | John T. Bigalke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 4,098 | 13,013 (0%) | 0% | 0 | Class A Common Stock | |
Biora Therapeutics Inc | John T. Bigalke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 51,724 | 51,724 | - | - | Stock Option (Right to Buy) | |
Biora Therapeutics Inc | John T. Bigalke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 29,183 | 47,518 | - | 0 | Common Stock |